
LIAISON offers the only antibody-based 25-Hydroxyvitamin D assay, which measures both Vitamin D2 (25-OHD2) and Vitamin D3 (25-OHD3), in an automated, random access chemiluminescence platform. Research findings indicate that the requirement for Vitamin D increases with age and in some cases, medication intervention has helped reduce the risk of bone disease. With the increase in the aging population, measuring the correct levels of circulating 25-Hydroxyvitamin D is more important than ever. Testing with the LIAISON 25-OH Vitamin D and LIAISON N-TACT PTH assays provides accurate and definitive analysis of nutritional Vitamin D deficiency.
Additional specialized assays in the areas of hepatitis, infectious diseases, and autoimmune disorders will be added to the LIAISON menu in the future.
DiaSorin Inc
(800) 328-1482; www.diasorin.com